#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Waldenstrom's macroglobulinaemia Systemic lupus erythematosus Loss of consciousness Leiomyosarcoma metastatic Oesophageal squamous cell carcinoma stage III Small intestine leiomyosarcoma Still's disease Epidermolysis bullosa Anti-myelin-associated glycoprotein associated polyneuropathy Primary biliary cholangitis Acute myeloid leukaemia recurrent Carcinoid tumour Leukoencephalopathy KBG syndrome High-grade B-cell lymphoma More trials…

    Learn about Rare Diseases

    Antithrombin III deficiency – Treatment Lennox-Gastaut syndrome – Basic Information Glycogen storage disease type V – Trials in Disease Chronic granulomatous disease – Treatment Immunodeficiency congenital – Basic Information Metachromatic leukodystrophy – Basic Information Combined immunodeficiency – Basic Information Angiosarcoma – Basic Information Tuberous sclerosis complex Undifferentiated sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Octreotide Ads-010 Abelacimab Ibrexafungerp HEMOPEXIN, HUMAN Rmc-035 Pelareorep Calcium Oxogluric Acid Gadoteric Acid Quetiapine Niraparib Tosilate Monohydrate Dotatate USNOFLAST Zasocitinib L-Glutamic Acid Mercaptopurine Anastrozole Deupirfenidone Dicloxacillin More therapies…

    Learn about Your Condition

    Growth hormone deficiency Hydrocephalus Thromboangiitis obliterans Status epilepticus Neuroendocrine carcinoma Anal cancer Lung adenocarcinoma Osteomyelitis Pelvic venous thrombosis Habitual abortion Diarrhoea Appendicitis Nephroblastoma Spina bifida Laryngeal leukoplakia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Atezolizumab, Bevacizumab, Oxaliplatin, and Capecitabine in Patients with Colorectal Cancer and Liver Metastasis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastases to liver
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Atezolizumab
    • Capecitabine
    France

  • Study on Senicapoc for Patients with Progressive Fibrotic Interstitial Lung Disease to Prevent Disease Progression

    Recruiting

    2 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Senicapoc
    • Placebo
    Denmark Estonia

  • Study comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Iron deficiency anaemia
    Investigated Drugs:
    • Ferumoxytol
    • Iron Sucrose
    Lithuania Poland

  • Study on Mepolizumab and Surgery for Patients with Chronic Rhinosinusitis with Nasal Polyps

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Mepolizumab
    Denmark

  • Comparison of dapagliflozin versus metformin treatment in patients with early stage type 2 diabetes to evaluate survival and complications

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dapagliflozin Propanediol
    Sweden

  • Study on Preserving the Rectum in Early-Stage Rectal Cancer Patients Using Oxaliplatin and Capecitabine with Radiation Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Rectal cancer
    Investigated Drugs:
    • Capecitabine
    • Oxaliplatin
    The Netherlands
Previous Page
1 … 355 356 357 358 359 … 1,650
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!